Esperion Therapeutics, Inc. 0IIM.L
0IIM.L
Esperion Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0JDK.L
Iovance Biotherapeutics, Inc. 0HX7.L
Adicet Bio, Inc. 0IFK.L
Editas Medicine, Inc. 0IV3.L
Geron Corporation 0IGA.L
Emergent BioSolutions Inc. 0LOV.L
Verastem, Inc. 0H8T.L
Aclaris Therapeutics, Inc.
Esperion Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0JDK.L
Iovance Biotherapeutics, Inc. 0HX7.L
Adicet Bio, Inc. 0IFK.L
Editas Medicine, Inc. 0IV3.L
Geron Corporation 0IGA.L
Emergent BioSolutions Inc. 0LOV.L
Verastem, Inc. 0H8T.L
Aclaris Therapeutics, Inc.
Performance
| Periode | 0IIM.L | 0R1D.L | 0J4V.L | 0JDK.L | 0HX7.L | 0IFK.L | 0IV3.L | 0IGA.L | 0LOV.L | 0H8T.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 164.43 % | -4.72 % | -29.51 % | -32.92 % | 102.02 % | 195.97 % | 1.55 % | 114.05 % | 94.17 % | 63.97 % |
| YTD | 14.45 % | -36.11 % | -20.86 % | -72.90 % | 5.51 % | 174.36 % | -63.91 % | -8.05 % | 39.90 % | -25.12 % |
| 1Y | 32.55 % | -26.72 % | -27.12 % | -78.07 % | -27.14 % | 18.95 % | -68.51 % | 4.94 % | 187.71 % | 57.19 % |
| 3Y | -67.07 % | -85.55 % | -64.05 % | -76.12 % | -93.22 % | -69.04 % | -44.26 % | -54.16 % | 87.85 % | -88.43 % |
| 5Y | -40.85 % | -88.76 % | -93.87 % | -91.05 % | -92.51 % | -81.08 % | -24.28 % | -90.45 % | -70.90 % | -73.10 % |
| 10Y | -40.85 % | -88.76 % | -94.69 % | -91.05 % | -92.51 % | -81.08 % | -35.15 % | -82.00 % | -78.77 % | -92.25 % |
| From the beginning | -40.85 % | -88.76 % | -94.69 % | -91.05 % | -92.51 % | -81.08 % | -35.15 % | -82.00 % | -78.77 % | -92.25 % |